Global Fluoropolymer in Healthcare Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Fluoropolymer in Healthcare market size was valued at US$ 753 million in 2024 and is forecast to a readjusted size of USD 1010 million by 2031 with a CAGR of 4.3% during review period.

Fluoropolymers are fluorocarbon based polymers formed by strong bonds between carbon and fluorine, which makes them mechanically stable. They are high-performance plastics with high acid, alkali and solvent resistance. Various fluoropolymer products, such as polytetrafluoroethylene (PTFE), polyvinylidene fluoride (PVDF), fluorinated ethylene propylene (FEP), ethylene tetrafluoroethylene (ETFE), polytrifluoroethylene (PCTFE), polyfluoroethylene (PVF), ethylene trifluoroethylene (ECTFE), perfluoroalkoxy (PFA), and fluoroelastomers are usually used in the medical market.

Based on geography, the Fluoropolymer In Healthcare market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Regionally, North America, Europe and Asia-Pacific are the major market of fluoropolymer in medical market. Due to the contact with the liquid medicine or the human body, the basic requirements of medical plastics are chemical stability and biological safety. The components in the plastic material cannot be precipitated into the liquid or the human body, will not cause toxicity and damage to tissues and organs, and are non-toxic and harmless to the human body. In order to ensure the biosafety of medical plastics, the medical plastics usually sold in the market are certified and tested by medical authorities, and users are clearly informed which grades are medical grade. Requirement in different region are also different. For USA, Fluoropolymer medical product usually pass FDA certification and USPVI biological testing, in Europe, the fluoropolymer needs CE certification, In China, medical-grade fluoropolymer are usually tested by Shandong Medical Device Testing Center.

PTFE was the dominant product segment and accounted for Nearly 59.03% share of the overall medical Fluoropolymer compounds market in 2023. PTFE is a soft polymer widely used as the porous material in pre-sterilized single-use medical applications such as filtration membrane and material. Increasing demand for PTFE in the disposable consumables is anticipated to fuel growth over the forecast period. FEP and PFA are more often used as tubing material in Drug Delivery and Medical Devices.

The medical disposables segment was valued at over 265 Million USD in 2023. This segment accounted for a large market share in terms of demand owing to the increasing usage of sterilized and disposable consumables in the healthcare sector due to the impact of COVID-19. In pharmaceutical packaging, the demand is stalely increased as the growing need for high barrier packaging material.

Medical Devices market, PTFE has been successfully marketed by Gore in the field of wound management materials and as fibers in blood purification devices. Also, Fluoropolymer coating material for medical device provide dry lubrication, insulation, and non-stick properties. Fluoropolymer for Drug Delivery market is usually consumed as coating material due to its insulation properties.

North America is the most mature market of fluoropolymer in the worldwide. The medical grade fluoropolymer market in North America is mainly concentrated in USA, with 3M, Chemours Daikin and Gore as the main company. Market in USA has been growing at over global average level for the past several years. USP defines the criteria for testing biological reactivity and the amount/type of extractables. The hygienic fluoropolymer in service must meet USP Class VI specifications.

In North America, USA is the major market of fluoropolymer in healthcare market with sales volume market share reached to 92 % in 2023. The market growth rate in USA is higher than global average rate as well as Europe. Major supplier from USA are Chemours, Saint-Gobain, W.L.Gore & Associates., Arkema, Zeus and Donaldson. Among these suppliers, Chemours and Gore are the key supplier in this region. There is no major supplier in Canada, so Canada is the net importer of fluoropolymer in healthcare market.

For Chemours, Teflon™ PTFE and PFA tubing are major type of injection grade fluoropolymer product in North America. The product has the advantages of high temperature resistance, voltage resistance, corrosion resistance, wear resistance, good self-sliding, transparency and hardness. Extruded tubing, heat shrink tubing and multi-lumen tubing are high purity, smooth, non-toxic, non-allergic, and compatible with human tissues and fluids, so many products have been chosen by the medical industry. For example, fluoropolymer heat shrinkable tube products are widely used in the continuation of medical device delivery tubes, etc. The heat-shrinkable tube is non-toxic, lubricated surface and non-stick, preventing the sticking and removal of harmful and toxic matter.

The working temperature of PTFE heat shrinkable tube is -65-260°C, and the working temperature of FEP heat shrinkable tube is -80-200°C. It can be seen that the working temperature range of PTFE heat shrinkable tube is larger than that of FEP heat shrinkable tube. Also, PTFE heat shrink tubing has two shrink ratios 1.7:1 and 4:1, while FEP heat shrink tubing has only one shrink ratio 1.7:1. However, PTFE is opaque, which makes liquid in the tube hard to be observed. A feature of FEP-heat shrink tubing is transparency and light penetration, so FEP-heat shrink tubing is typically used in applications with low shrink temperature, greater flexibility, and higher requirements for light transmittance and lubrication. The demand for PTFE and FEP can’t be replaced by each other. Specific application of PTFE and FEP heat shrinkable connection tube are medical cotton swabs, disposable medical devices, orthopedic support frames, endoscopes, washable telescopic devices, etc.

Gore is the main company that develop the use of PTFE in medical membrane. In 1975, the first GORE-TEX® Vascular Graft is commercialized, launching Gore’s medical business. In 1981, Gore launches its first medical ePTFE patch product, the GORE-TEX® Cardiovascular Patch. In 1997, Gore introduces its first minimally-invasive endovascular prosthesis, marrying ePTFE grafts with Nitinol stents. In 2018, GORE® Improject Plunger unveiled. Provides the only option for siliconefree delivery of sensitive biologicals. Also,. Gore developed PTFE venting membrane for use of medical filtration. Some medical liquids contain entrained gas which may present a hazard to the patient or affect the proper operation of a medical device. GORE Microfiltration Media for Medical Devices is designed for high levels of gas permeability which can allow for fast pressure equalization and airflow. For instance, in IV lines, GORE Media aids in the dissipation of these gas bubbles while retaining liquids that are under pressure.

This report is a detailed and comprehensive analysis for global Fluoropolymer in Healthcare market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Fluoropolymer in Healthcare market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031

Global Fluoropolymer in Healthcare market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031

Global Fluoropolymer in Healthcare market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (US$/Kg), 2020-2031

Global Fluoropolymer in Healthcare market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (US$/Kg), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Fluoropolymer in Healthcare

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Fluoropolymer in Healthcare market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chemours, Daikin, Solvay, 3M, AGC, Saint-Gobain, W.L.Gore & Associates, Arkema, Gujarat, HaloPolymer, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Fluoropolymer in Healthcare market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
PTFE
PVDF
FEP
PFA
Others

Market segment by Application
Medical Disposables
Pharmaceutical Packaging
Medical Devices
Drug Delivery
Others

Major players covered
Chemours
Daikin
Solvay
3M
AGC
Saint-Gobain
W.L.Gore & Associates
Arkema
Gujarat
HaloPolymer
Zeus
Donaldson

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Fluoropolymer in Healthcare product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Fluoropolymer in Healthcare, with price, sales quantity, revenue, and global market share of Fluoropolymer in Healthcare from 2020 to 2025.

Chapter 3, the Fluoropolymer in Healthcare competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Fluoropolymer in Healthcare breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Fluoropolymer in Healthcare market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Fluoropolymer in Healthcare.

Chapter 14 and 15, to describe Fluoropolymer in Healthcare sales channel, distributors, customers, research findings and conclusion.